Cristina Abreu has received research support from Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, and Lilly, and has acted as a speaker for Sanofi, Novo Nordisk, Boehringer Ingelheim Pharmaceuticals, AstraZeneca Pharmaceuticals LP, and Bristol-Myers Squibb Co
I decided to just try it for a month and see what I thought
Journal of Pharmaceutical Research Year: 2026, Volume: 25, Issue: 1, Pages: 16-19 Review Article Sagarika Basavaraj 1* , Aparna Chincholkar 2 1 Junior Resident, Department of Pharmacology, MAEER'S MIT Pune's MIMER Medical College and Dr BSTR Hospital, Talegaon Dhabade, Pune- 410507, Maharashtra, India 2 Professor, Department of Pharmacology, MAEER'S MIT Pune's MIMER Medical College and Dr BSTR Hospital, Talegaon Dhabade, Pune- 410507, Maharashtra, India *Corresponding Author Sagarika Basavaraj Email: [email protected] Obesity is a chronic, relapsing disease associated with significant cardiometabolic, mechanical, and psychological consequences
Cost : Semaglutide can be expensive, especially without insurance coverage, making it less affordable for some people